Altoida Inc
Altoida Inc, based in Washington, DC, is revolutionizing neurology diagnostics with its innovative NeuroMarker Platform, designed to enable early detection of cognitive decline through a rapid and objective assessment process. By utilizing neuroscience-driven tasks and sensor-based data, Altoida's platform significantly improves upon traditional cognitive assessments, allowing healthcare providers to intervene sooner when treatment is most effective.
The NeuroMarker Platform offers a self-administered assessment that takes just 10 minutes, contrasting sharply with the lengthy and often less sensitive traditional methods. Built on over two decades of scientific research, Altoida aims to enhance cognitive health assessments not only for Mild Cognitive Impairment and Alzheimer's disease but also for a broader range of central nervous system disorders.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.




